Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $17,078 - $20,755
65 Added 1.79%
3,706 $1.16 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $130,401 - $157,411
-485 Reduced 11.75%
3,641 $1.04 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $24,547 - $27,692
96 Added 2.38%
4,126 $1.19 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $55,318 - $68,679
253 Added 6.7%
4,030 $1.08 Million
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $11,999 - $14,188
-56 Reduced 1.46%
3,777 $838,000
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $48,319 - $58,892
-214 Reduced 5.29%
3,833 $926,000
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $71,915 - $91,377
-314 Reduced 7.2%
4,047 $1.06 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $6,229 - $6,931
27 Added 0.62%
4,361 $1.06 Million
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $3,727 - $4,123
-17 Reduced 0.39%
4,334 $1.05 Million
Q4 2021

Feb 08, 2022

BUY
$198.88 - $227.6 $865,326 - $990,287
4,351 New
4,351 $979,000
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $201,019 - $235,518
-947 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $1,775 - $2,068
-8 Reduced 0.84%
947 $236,000
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $16,012 - $19,067
-74 Reduced 7.19%
955 $220,000
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $41,298 - $45,927
-176 Reduced 14.61%
1,029 $261,000
Q2 2020

Aug 04, 2020

BUY
$197.81 - $242.74 $238,361 - $292,501
1,205 New
1,205 $284,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Quadrant Private Wealth Management, LLC Portfolio

Follow Quadrant Private Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Private Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Private Wealth Management, LLC with notifications on news.